Advances in Cancer ResearchSeries Editor:
- George Vande Woude, Director, Van Andel Research Institute, Grand Rapids, MI, USA
- George Klein, Karolinska Institutet, Stockholm, Sweden
The Advances in Cancer Research series provides invaluable information on the exciting and fast-moving field of cancer research. This volume presents outstanding and original reviews on a variety of topics, including suppressor and oncogenic roles of TGF-b and its signaling pathways in tumorigenesis, hereditary diffuse gastric disease, the role of heparan sulfate proteoglycans in cell signaling and cancer, V-gene mutations in B-cell-derived human malignancy, MHC antigens and tumor escape from immune surveillance, the role of selection in progressive neoplastic transformation, and the genomic stability, neuronal development, and cancer cross paths of ATM.
Researchers and students in the basic and clinical science of cancer biology and oncology, plus related areas in genetics, immunology, pharmacology, cell biology, and molecular biology.
Advances in Cancer Research
Hardbound, 261 Pages
Published: October 2001
Imprint: Academic Press
"This classic and essential series presents critical overviews on select aspects of both cancer research and the basis underlying sciences."
Praise for the Serial: , AMERICAN SCIENTIST
"Excellent, highly informative, in-depth reviews...expertly written, up-to-date, and well-referenced."
JOURNAL OF MEDICINAL CHEMISTRY
"This is a series that has a long tradition of excellence in the field of cancer biology."
DOODY'S PUBLISHING REVIEWS